AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott.
AbbVie combines the focus and passion of a leadingedge biotech with the expertise and capabilities of a long-established pharmaceutical leader to develop and market advanced therapies that address some of the world’s most complex and serious diseases. In 2013, AbbVie will employ approximately 21,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com. Follow @AbbVie on Twitter or view careers on our Facebook page.
AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
The mission of Danone Research is to bring health through food to the greatest number of people.
With 150 manufacturing sites and over 75,000 employees, Danone is a health food leader. The waters division of the Danone Group encompasses several well known international brands including Evian, Volvic, Badoit and Bonafont, as well as leading national brands such as Aqua (Indonesia), Villavicencio, Villa del Sur (Argentina), Zywiec Zdroj (Poland), Hayat (Turkey), Fontvella, Lanjaron (Spain), Salus (Uruguay), Robust, Health (China) and Salvetat (France). Danone is committed to promoting healthy hydration. Our aim is to encourage scientific advances in hydration studies, and ensure the diffusion and application of this information through our the Hydration for Health Initiative.
Sanofi, a global and diversified healthcare leader discovers, develops and distributes therapeutic solutions focused on patients’ needs.
Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme.